GlassScriptPhysician profile
Matthew Moss
NPI 1801478714
$2,346.82
in general payments reported to CMS, 2019-2025
20 companies · $964 in 2025
The $964 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $292 · 2023: $582 · 2024: $363 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,058.32 | 2021-2025 | Accolade Sr, Lithovue, Rezum Generator |
| Medtronic, INC. | $191.38 | 2023-2025 | Interstim |
| Ferring Pharmaceuticals INC. | $137.15 | 2025 | Adstiladrin |
| Coloplast Corp | $130.73 | 2024-2025 | |
| Olympus America INC. | $124.09 | 2023 | Soltive |
| Progenics Pharmaceuticals, INC. | $118.83 | 2024-2025 | |
| Teleflex LLC | $107.30 | 2025 | Barrigel |
| Astellas Pharma US INC | $103.82 | 2022-2024 | Xtandi |
| Stryker Corporation | $74.92 | 2023 | Fluid Safe |
| Endo USA, INC. | $41.68 | 2025 | Xiaflex |
| Sumitomo Pharma America, INC. | $33.66 | 2023 | Gemtesa |
| Innovation Technologies INC | $29.37 | 2023 | Irrisept |
| Dendreon Pharmaceuticals LLC | $29.10 | 2024 | Provenge |
| Janssen Biotech, INC. | $27.98 | 2025 | Erleada |
| Endo Pharmaceuticals INC. | $27.35 | 2023 | Xiaflex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.82 | 2021 | |
| Photocure INC | $22.67 | 2025 | Cysview |
| Axonics, INC. | $22.40 | 2023 | Bulkamid |
| Travere Therapeutics, INC. | $21.18 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.